Annual ROE
-136.47%
-79.10%-137.88%
December 31, 2023
Summary
- As of February 24, 2025, SGMO annual return on equity is -136.47%, with the most recent change of -79.10% (-137.88%) on December 31, 2023.
- During the last 3 years, SGMO annual ROE has fallen by -110.45% (-424.48%).
- SGMO annual ROE is now -748.17% below its all-time high of -16.09%, reached on December 31, 2014.
Performance
SGMO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-199.86%
+34.87%+14.86%
September 30, 2024
Summary
- As of February 24, 2025, SGMO quarterly return on equity is -199.86%, with the most recent change of +34.87% (+14.86%) on September 30, 2024.
- Over the past year, SGMO quarterly ROE has dropped by -80.72% (-67.75%).
- SGMO quarterly ROE is now -1647.03% below its all-time high of -11.44%, reached on March 31, 2015.
Performance
SGMO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SGMO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -137.9% | -67.8% |
| 3 y3 years | -424.5% | -415.5% |
| 5 y5 years | -454.3% | -737.3% |
SGMO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -234.0% | at low | -400.5% | +14.9% |
| 5 y | 5-year | -473.4% | at low | -1101.1% | +14.9% |
| alltime | all time | -748.2% | at low | -1647.0% | +14.9% |
Sangamo Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -199.86%(-14.9%) |
| Jun 2024 | - | -234.73%(+20.7%) |
| Mar 2024 | - | -194.40%(+63.2%) |
| Dec 2023 | -136.47%(+137.9%) | -119.14%(+24.9%) |
| Sep 2023 | - | -95.36%(+43.3%) |
| Jun 2023 | - | -66.54%(+66.6%) |
| Mar 2023 | - | -39.93%(-32.2%) |
| Dec 2022 | -57.37%(+40.4%) | -58.90%(+15.5%) |
| Sep 2022 | - | -51.00%(+11.3%) |
| Jun 2022 | - | -45.84%(+5.6%) |
| Mar 2022 | - | -43.41%(+6.8%) |
| Dec 2021 | -40.86%(+57.0%) | -40.64%(+4.8%) |
| Sep 2021 | - | -38.77%(+40.1%) |
| Jun 2021 | - | -27.67%(+6.8%) |
| Mar 2021 | - | -25.91%(+0.9%) |
| Dec 2020 | -26.02%(+9.3%) | -25.67%(+54.3%) |
| Sep 2020 | - | -16.64%(-27.8%) |
| Jun 2020 | - | -23.05%(-2.9%) |
| Mar 2020 | - | -23.73%(-0.6%) |
| Dec 2019 | -23.80%(-3.3%) | -23.87%(-21.7%) |
| Sep 2019 | - | -30.49%(+12.1%) |
| Jun 2019 | - | -27.21%(-0.8%) |
| Mar 2019 | - | -27.42%(+20.8%) |
| Dec 2018 | -24.62%(-26.9%) | -22.70%(-4.2%) |
| Sep 2018 | - | -23.69%(-13.4%) |
| Jun 2018 | - | -27.34%(-17.5%) |
| Mar 2018 | - | -33.15%(+0.9%) |
| Dec 2017 | -33.67%(-22.8%) | -32.85%(+1.1%) |
| Sep 2017 | - | -32.49%(-14.5%) |
| Jun 2017 | - | -37.98%(-21.2%) |
| Mar 2017 | - | -48.18%(+9.2%) |
| Dec 2016 | -43.61%(+113.8%) | -44.13%(+2.1%) |
| Sep 2016 | - | -43.24%(+22.0%) |
| Jun 2016 | - | -35.45%(+34.3%) |
| Mar 2016 | - | -26.39%(+31.0%) |
| Dec 2015 | -20.40%(+26.8%) | -20.15%(+33.5%) |
| Sep 2015 | - | -15.09%(+6.9%) |
| Jun 2015 | - | -14.11%(+23.3%) |
| Mar 2015 | - | -11.44%(-15.9%) |
| Dec 2014 | -16.09%(-43.6%) | -13.61%(-19.9%) |
| Sep 2014 | - | -16.99%(-12.9%) |
| Jun 2014 | - | -19.51%(-16.2%) |
| Mar 2014 | - | -23.29%(-24.1%) |
| Dec 2013 | -28.54%(-7.0%) | -30.69%(+5.8%) |
| Sep 2013 | - | -29.01%(-13.4%) |
| Jun 2013 | - | -33.49%(+3.3%) |
| Mar 2013 | - | -32.42%(+3.7%) |
| Dec 2012 | -30.70%(-41.6%) | -31.27%(-6.7%) |
| Sep 2012 | - | -33.50%(-7.2%) |
| Jun 2012 | - | -36.09%(-18.1%) |
| Mar 2012 | - | -44.07%(-11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -52.56%(+35.0%) | -49.52%(-10.1%) |
| Sep 2011 | - | -55.06%(-2.4%) |
| Jun 2011 | - | -56.39%(+13.0%) |
| Mar 2011 | - | -49.89%(+31.6%) |
| Dec 2010 | -38.93%(+33.2%) | -37.91%(+26.7%) |
| Sep 2010 | - | -29.91%(+19.7%) |
| Jun 2010 | - | -24.98%(-10.0%) |
| Mar 2010 | - | -27.76%(-19.7%) |
| Dec 2009 | -29.23%(-23.3%) | -34.57%(-6.8%) |
| Sep 2009 | - | -37.09%(-1.4%) |
| Jun 2009 | - | -37.62%(-6.3%) |
| Mar 2009 | - | -40.15%(+2.6%) |
| Dec 2008 | -38.12%(+7.2%) | -39.12%(-8.8%) |
| Sep 2008 | - | -42.90%(+2.6%) |
| Jun 2008 | - | -41.80%(+3.5%) |
| Mar 2008 | - | -40.38%(+5.5%) |
| Dec 2007 | -35.56%(-13.9%) | -38.28%(-16.4%) |
| Sep 2007 | - | -45.80%(-2.9%) |
| Jun 2007 | - | -47.18%(+7.0%) |
| Mar 2007 | - | -44.08%(+11.6%) |
| Dec 2006 | -41.30%(+9.0%) | -39.49%(+36.0%) |
| Sep 2006 | - | -29.04%(-18.3%) |
| Jun 2006 | - | -35.54%(-14.1%) |
| Mar 2006 | - | -41.39%(-8.1%) |
| Dec 2005 | -37.88%(+5.6%) | -45.02%(-4.5%) |
| Sep 2005 | - | -47.12%(+4.7%) |
| Jun 2005 | - | -45.00%(+11.1%) |
| Mar 2005 | - | -40.52%(+13.6%) |
| Dec 2004 | -35.87%(+70.0%) | -35.67%(+18.7%) |
| Sep 2004 | - | -30.05%(+26.6%) |
| Jun 2004 | - | -23.73%(+5.4%) |
| Mar 2004 | - | -22.52%(+5.6%) |
| Dec 2003 | -21.10%(-51.6%) | -21.33%(+14.8%) |
| Sep 2003 | - | -18.58%(-62.0%) |
| Jun 2003 | - | -48.93%(+9.3%) |
| Mar 2003 | - | -44.78%(+4.0%) |
| Dec 2002 | -43.58%(+28.8%) | -43.07%(-0.2%) |
| Sep 2002 | - | -43.15%(+15.2%) |
| Jun 2002 | - | -37.47%(+1.7%) |
| Mar 2002 | - | -36.83%(+6.2%) |
| Dec 2001 | -33.84%(+39.6%) | -34.69%(-1.7%) |
| Sep 2001 | - | -35.30%(+159.2%) |
| Jun 2001 | - | -13.62%(-9.8%) |
| Mar 2001 | - | -15.10%(-11.5%) |
| Dec 2000 | -24.24%(-63.9%) | -17.06%(+32.4%) |
| Sep 2000 | - | -12.89%(+12.6%) |
| Jun 2000 | - | -11.45%(-62.7%) |
| Mar 2000 | - | -30.68% |
| Dec 1999 | -67.23%(+0.4%) | - |
| Dec 1998 | -66.95%(+63.6%) | - |
| Dec 1997 | -40.92%(-42.3%) | - |
| Dec 1996 | -70.97% | - |
FAQ
- What is Sangamo Therapeutics annual return on equity?
- What is the all time high annual ROE for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual ROE year-on-year change?
- What is Sangamo Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly ROE year-on-year change?
What is Sangamo Therapeutics annual return on equity?
The current annual ROE of SGMO is -136.47%
What is the all time high annual ROE for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual return on equity is -16.09%
What is Sangamo Therapeutics annual ROE year-on-year change?
Over the past year, SGMO annual return on equity has changed by -79.10% (-137.88%)
What is Sangamo Therapeutics quarterly return on equity?
The current quarterly ROE of SGMO is -199.86%
What is the all time high quarterly ROE for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly return on equity is -11.44%
What is Sangamo Therapeutics quarterly ROE year-on-year change?
Over the past year, SGMO quarterly return on equity has changed by -80.72% (-67.75%)